CytomX Therapeutics (CTMX) Leases (2017 - 2025)
Historic Leases for CytomX Therapeutics (CTMX) over the last 9 years, with Q3 2025 value amounting to $4.8 million.
- CytomX Therapeutics' Leases fell 4763.41% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 4763.41%. This contributed to the annual value of $8.1 million for FY2024, which is 3342.06% down from last year.
- Per CytomX Therapeutics' latest filing, its Leases stood at $4.8 million for Q3 2025, which was down 4763.41% from $5.9 million recorded in Q2 2025.
- In the past 5 years, CytomX Therapeutics' Leases ranged from a high of $21.7 million in Q1 2021 and a low of $4.8 million during Q3 2025
- Its 5-year average for Leases is $13.8 million, with a median of $14.1 million in 2023.
- Per our database at Business Quant, CytomX Therapeutics' Leases plummeted by 1193.58% in 2021 and then tumbled by 4763.41% in 2025.
- Quarter analysis of 5 years shows CytomX Therapeutics' Leases stood at $19.4 million in 2021, then dropped by 17.63% to $15.9 million in 2022, then decreased by 23.38% to $12.2 million in 2023, then crashed by 33.42% to $8.1 million in 2024, then crashed by 40.83% to $4.8 million in 2025.
- Its last three reported values are $4.8 million in Q3 2025, $5.9 million for Q2 2025, and $7.1 million during Q1 2025.